Specialists in cell-free RNA Biomarkers,
Extracellular Vesicles, and Diagnostics
— at your service
Tamirna_Hand_blue_gloves_workin_in_laboratory
home2026-09-23T08:57:52+02:00

biomarkers for more stability in life

Our Mission:
RNA biomarkers for precision medicine

discovery_and_validation_of_microRNA_biomarkers

TAmiRNA is dedicated to supporting researchers and clinicians in RNA biomarker discovery, validation, and development. Our mission is to provide innovative diagnostic solutions that improve patient outcomes, with a focus on precision medicine and age-associated diseases.

TAmiRNA - stability for live

Our Expertise:
RNA signatures and diagnostics

mircoRNA_signatures

We specialize in biomarker discovery using cell-free RNAs, including microRNAs, mRNAs, and long non-coding RNAs (lncRNAs). By integrating RNA signatures with AI-driven analysis, we develop actionable diagnostic solutions that enhance disease detection and patient stratification.

TAmiRNA - stability for live

Our Focus:
biomarker discovery for complex diseases

age_associated_diseases

TAmiRNA drives R&D and contract research in liver disease, senescence, cardiovascular disease, oncology, and bone and joint disorders. Using advanced transcriptomic approaches, we aim to decode disease mechanisms, personalize diagnostics, and accelerate biomarker-driven innovations.

TAmiRNA - stability for live

biomarkers for more stability in life

Our Mission:
RNA biomarkers for precision medicine

discovery_and_validation_of_microRNA_biomarkers

TAmiRNA is dedicated to supporting researchers and clinicians in RNA biomarker discovery, validation, and development. Our mission is to provide innovative diagnostic solutions that improve patient outcomes, with a focus on precision medicine and age-associated diseases.

Our Focus:
biomarker discovery for complex diseases

mircoRNA_signatures

TAmiRNA drives R&D and contract research in liver disease, senescence, cardiovascular disease, oncology, and bone and joint disorders. Using advanced transcriptomic approaches, we aim to decode disease mechanisms, personalize diagnostics, and accelerate biomarker-driven innovations.

Our Expertise:
RNA signatures and diagnostics

We specialize in biomarker discovery using cell-free RNAs, including microRNAs, mRNAs, and long non-coding RNAs (lncRNAs). By integrating RNA signatures with AI-driven analysis, we develop actionable diagnostic solutions that enhance disease detection and patient stratification.

Services

Transcriptomic services

services

Exploring microRNAs, mRNAs, circular RNAs, or other non-coding RNAs?

TAmiRNA offers validated solutions for targeted (RT-qPCR) and untargeted (NGS-based) RNA analysis in serum, plasma, urine, saliva, milk, EVs, exosomes, cells, and tissues. With 11+ years of RNA biomarker expertise, we ensure reliable results and project success.

TAmiRNA - the power of microRNA biomarkers

RNA biomarker services

Interested in our microRNA disease panels or IVD/RUO kits but lack the time or resources for in-house analysis?

Send us your samples, and our in-house services will deliver results for hepatomiR®, senomiR®, toxomiR®, osteomiR®, and thrombomiR®. We also support custom miRNA or mRNA signature analysis by implementing tailored workflows.

TAmiRNA - the power of microRNA biomarkers
Click_here_for_your_personalized_microRNA_service_offer

services

Transcriptomic services

services

Exploring microRNAs, mRNAs, circular RNAs, or other non-coding RNAs?

TAmiRNA offers validated solutions for targeted (RT-qPCR) and untargeted (NGS-based) RNA analysis in serum, plasma, urine, saliva, milk, EVs, exosomes, cells, and tissues. With 11+ years of RNA biomarker expertise, we ensure reliable results and project success.

TAmiRNA - the power of microRNA biomarkers

RNA biomarker services

You are interested in our microRNA disease panels or IVD/RUO kits, but don´t have the time or resources to analyse in your lab?

You can send us your samples to obtain results for hepatomiR®, senomiR®, toxomiR®, osteomiR®, or thrombomiR® by taking advantage of our in-house services. In addition, we can support the analysis of your specific miRNA or mRNA signature by implementing a tailored workflow or kit.

TAmiRNA - the power of microRNA biomarkers
TAmiRNA - stability for live

Products

TAmiRNA - stability for live
TAmiRNA - stability for live
TAmiRNA - stability for live

our products

TAmiRNA - stability for live
TAmiRNA - stability for live
TAmiRNA - stability for live

latest news

New evidence on variability of plasma miR-122 published with contribution of TAmiRNA

By |September 22nd, 2026|Categories: biomarker, circulating miRNAs, DILI, drug-induced liver injury, microRNA services, miND, miND spike ins, RNA, small RNA-sequencing, smallRNA, TransBioLine|Tags: , , , , , , , , , |

A short communication published in the British Journal of Clinical Pharmacology re-evaluates the inter- and intra-individual variability of circulating miR-122 in healthy volunteers, using small RNA sequencing generated on [...]

TAmiRNA Joins Six European RNA Specialists to Launch the European RNA Alliance

By |September 8th, 2026|Categories: biomarker, circulating miRNAs, ERA, European RNA Alliance, EV characterization, exosomes, extracellular vesicle, microRNA services, miND, miND spike ins, RNA, small RNA-sequencing, smallRNA|Tags: , , , , , , , , , , , , |

As a founding member of ERA, TAmiRNA positions itself as the innovative driving force behind RNA biomarker development in Europe — combining novel biomarker products with premier research services [...]

TAmiRNA is a Silver Sponsor at the D-A-CH EV Meeting 2026 in Erlangen

By |September 1st, 2026|Categories: biomarker, circulating miRNAs, Conference, EV characterization, exosomes, extracellular vesicle, microRNA services, miND, miND spike ins, RNA, small RNA-sequencing, smallRNA|Tags: , , , , , , , , , |

From September 28–30, 2026, the D-A-CH EV Meeting 2026 will take place at the Hörsaalzentrum of the Medical Faculty, University Hospital Erlangen — the first joint annual meeting of [...]

Comments Off on TAmiRNA is a Silver Sponsor at the D-A-CH EV Meeting 2026 in Erlangen

New evidence on variability of plasma miR-122 published with contribution of TAmiRNA

By |September 22nd, 2026|Categories: biomarker, circulating miRNAs, DILI, drug-induced liver injury, microRNA services, miND, miND spike ins, RNA, small RNA-sequencing, smallRNA, TransBioLine|Tags: , , , , , , , , , |

A short communication published in the British Journal of Clinical Pharmacology re-evaluates the inter- and intra-individual variability of circulating miR-122 in healthy volunteers, using small RNA sequencing generated on TAmiRNA's miND workflow [...]

TAmiRNA Joins Six European RNA Specialists to Launch the European RNA Alliance

By |September 8th, 2026|Categories: biomarker, circulating miRNAs, ERA, European RNA Alliance, EV characterization, exosomes, extracellular vesicle, microRNA services, miND, miND spike ins, RNA, small RNA-sequencing, smallRNA|Tags: , , , , , , , , , , , , |

As a founding member of ERA, TAmiRNA positions itself as the innovative driving force behind RNA biomarker development in Europe — combining novel biomarker products with premier research services in cell-free RNA [...]

TAmiRNA is a Silver Sponsor at the D-A-CH EV Meeting 2026 in Erlangen

By |September 1st, 2026|Categories: biomarker, circulating miRNAs, Conference, EV characterization, exosomes, extracellular vesicle, microRNA services, miND, miND spike ins, RNA, small RNA-sequencing, smallRNA|Tags: , , , , , , , , , |

From September 28–30, 2026, the D-A-CH EV Meeting 2026 will take place at the Hörsaalzentrum of the Medical Faculty, University Hospital Erlangen — the first joint annual meeting of the German, Austrian [...]

Comments Off on TAmiRNA is a Silver Sponsor at the D-A-CH EV Meeting 2026 in Erlangen
Go to Top